Herold Advisors, Inc. Haleon PLC Transaction History

Herold Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$7.85 - $8.94 $8,046 - $9,163	-1,025 Reduced 9.29%	10,009 $83,000
Q2 2023 Jul 14, 2023	SELL	$8.04 - $9.0 $6,946 - $7,776	-864 Reduced 7.26%	11,034 $92,000
Q1 2023 Apr 19, 2023	SELL	$7.57 - $8.37 $567 - $627	-75 Reduced 0.63%	11,898 $96,000
Q4 2022 Feb 14, 2023	SELL	$5.96 - $8.06 $94,460 - $127,742	-15,849 Reduced 56.97%	11,973 $95,000
Q3 2022 Nov 08, 2022	BUY	$5.63 - $7.5 $156,637 - $208,665	27,822 New	27,822 $169,000

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Herold Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Herold Advisors, Inc. with notifications on news.